- Own R&D centerOur own R&D center is equipped with unique European-class equipment that allows us to improve well-known drug formulas and create original drugs, which now account for up to a third part of the laboratories' development portfolio. The production and laboratory capabilities of the R&D center are used to scale processes, which, without loss of quality, significantly accelerates technology transfer to production facilities and ensures an increase in efficiency at the stages of debugging and launch of production of new drug products.
- Plant's production facilitiesMost of the plant's production facilities have been completely reconstructed or modernized after the plant was acquired by the Promomed Group. The best equipment according to international standards was installed, most of the processes are automated or robotized, which minimized the possibility of personnel errors.
- The quality control departmentThe quality control department conducts incoming control of raw materials and materials, intermediate and finished products, monitoring of the production environment in order to completely eliminate the risk of using materials or products that do not meet the established requirements.
- The quality assurance departmentThe quality assurance department impartially evaluates the compliance of production sites with GMP (Good Manufacturing Practice) standards. It conducts internal quality audits, remote and on-site audits of service providers, raw materials and materials, and monitors quality risk management activities.
Quality management system of the enterprise is certified against the requirements of GOST R ISO 9001 (ISO 9001:2015).PDF
GMP certificate No. GMP/EAEU/RU/0001475-2021 dated October 10, 2021 on the compliance of the manufacturer of medicines for medical use with the requirements of the Rules of Good Manufacturing Practice of the Eurasian Economic Union issued by the MinistryPDF
GMP certificate No. GMP-0075-000331/18 dated December 3, 2018, issued by the Ministry of Industry and Trade of the Russian Federation.JPEG
License to manufacture medicinal products dated April 26, 2019PNG